Concepedia

Efficacy and safety of etanercept combined plus methotrexate and comparison of expression of pro-inflammatory factors expression for the treatment of moderate-to-severe plaque psoriasis

Qian Yu, Yunlei Tong, Lian Cui, Lingling Zhang, Yu Gong, Hongyue Diao, Fei Gao, Yuling Shi

International Immunopharmacology · 2019 · 31 citations · 27 references

DOI

Concepts

References

27

Dermatology Life Quality Index (DLQI)-a simple practical measure for routine clinical use

A.Y. Finlay, Ghazala Khan · Clinical and Experimental Dermatology · 1994 · 5.5K citations

, , +8

Etanercept as Monotherapy in Patients with Psoriasis

Craig L. Leonardi, JEROLD L. POWERS, Robert Matheson et al. · New England Journal of Medicine · 2003 · 1.2K citations · Full text

, , +16

Etanercept and clinical outcomes, fatigue, and depression in psoriasis: double-blind placebo-controlled randomised phase III trial

Stephen K. Tyring, Alice B. Gottlieb, Kim Papp et al. · The Lancet · 2005 · 1.1K citations

, , +6

Serum Levels of TNF‐<i>α</i>, IFN‐<i>γ</i>, IL‐6, IL‐8,IL‐12, IL‐17, and IL‐18 in Patients With Active Psoriasis andCorrelation With Disease Severity

Özer Arıcan, Murat Aral, Sezai Şaşmaz · Mediators of Inflammation · 2005 · 792 citations · Full text

, , +17

Efficacy and safety results from the randomized controlled comparative study of adalimumab vs. methotrexate vs. placebo in patients with psoriasis (CHAMPION)

J.‐H. Saurat, G Stingl, Louis Dubertret et al. · British Journal of Dermatology · 2007 · 722 citations

, , +9